SANUWAVE Health, Inc. Common Stock (NASDAQ:SNWV) — Market Cap & Net Worth
Market Cap & Net Worth: SANUWAVE Health, Inc. Common Stock (SNWV)
SANUWAVE Health, Inc. Common Stock (NASDAQ:SNWV) has a market capitalization of $53.06 Million ($53.06 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21599 globally and #4772 in its home market, demonstrating a 4.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SANUWAVE Health, Inc. Common Stock's stock price $6.17 by its total outstanding shares 8598976 (8.60 Million). See SNWV capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
SANUWAVE Health, Inc. Common Stock Market Cap History: 2026 to 2026
SANUWAVE Health, Inc. Common Stock's market capitalization history from 2026 to 2026. Data shows growth from $53.06 Million to $53.06 Million (0.00% CAGR).
SANUWAVE Health, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SANUWAVE Health, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SNWV by Market Capitalization
Companies near SANUWAVE Health, Inc. Common Stock in the global market cap rankings as of August 3, 2026.
Key companies related to SANUWAVE Health, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
SANUWAVE Health, Inc. Common Stock Historical Marketcap From 2026 to 2026
Between 2026 and today, SANUWAVE Health, Inc. Common Stock's market cap moved from $53.06 Million to $ 53.06 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $53.06 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of SANUWAVE Health, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $53.06 Million USD |
| MoneyControl | $53.06 Million USD |
| MarketWatch | $53.06 Million USD |
| marketcap.company | $53.06 Million USD |
| Reuters | $53.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more